FDA-EMA Pilot Could Further Push Global Generic Harmonization, But Will Sponsors Use It?

The FDA-EMA parallel scientific advice pilot for complex generics is an expansion of the existing program for new drugs and biologics. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from Pathways & Standards